Home
Conditions
Lymphoma, Follicular

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Not Yet Recruiting

Tirzepatide in the Treatment of Cannabis Use Disorder

NCT07671248

Conditions: Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe, Hemic and Lymphatic Diseases, +9 more
Locations: MacAnxiety Research Centre Hamilton, Ontario, Canada

View Trial Details

Not Yet Recruiting

Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot Study

NCT07664787

Conditions: Cardiovascular Diseases, Grade 1, Hemic and Lymphatic Diseases, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

NCT07631598

Conditions: Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Community Health Project Los Angeles (CHPLA) Los Angeles, California, United States

HIPS Washington D.C., District of Columbia, United States

CARPBR/Be Safe Syringe Program Baton Rouge, Louisiana, United States

Harm Reduction Sisters Duluth, Minnesota, United States

View Trial Details

Not Yet Recruiting

Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

NCT07592481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Axatilimab + CAR-T for High-Risk Lymphoma

NCT07638982

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Digestive System Diseases, Follicular Grade 3 Lymphoma, +21 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Not Yet Recruiting

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

NCT07609446

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

A Exploratory Study on Untreated Follicular Lymphoma With Orelabrutinib, Tafasitamab, and Lenalidomide

NCT07585747

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Shenzhen Second People's Hospital Shenzhen, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

Qilu Hospital of Shandong Province Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

NCT07562022

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

NCT07550634

Conditions: Digestive System Diseases, Hemic and Lymphatic Diseases, Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B), +12 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma

NCT07550855

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Sun Yat-sen Universitiy Cancer Center Guangzhou, Guangdong, China

View Trial Details

Lymphoma, Follicular

Lymphoma, Follicular trial results

Related conditions